Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Conditions: Gynecologic Cancer; Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cavity Cancer Interventions: Drug: FT536; Drug: Fludarabine; Drug: CY Sponsors: Masonic Cancer Center, University of Minnesota Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Fallopian Tube Cancer | Ovarian Cancer | Ovaries | Peritoneal Cancer | Research | University of Minnesota